Home > Income Statement > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Revenue

    Back to Income Statement
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹581 Cr₹510 Cr₹472 Cr₹424 Cr₹386 Cr

What is the latest Revenue of LINCOLN PHARMACEUTICALS ?

The latest Revenue ratio of LINCOLN PHARMACEUTICALS is ₹581 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹581 Cr
Mar2023₹510 Cr
Mar2022₹472 Cr
Mar2021₹424 Cr
Mar2020₹386 Cr

How is Revenue of LINCOLN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹581 Cr
13.76
Mar2023 ₹510 Cr
8.09
Mar2022 ₹472 Cr
11.30
Mar2021 ₹424 Cr
9.75
Mar2020 ₹386 Cr -

Compare Revenue of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,043.4 Cr -6.8% -30.4% -15.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,246.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹147,119.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹116,805.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,554.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹93,192.0 Cr -0.9% -10% -11.3% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-6.8%

-30.4%

-15.7%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses